BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36544650)

  • 1. Pre-treatment FLT-PET parameters as a prognostic tool for patients with locally advanced recurrent nasopharyngeal carcinoma salvaged by carbon-ion radiotherapy: a pilot study.
    Hu J; Yang Z; Gao J; Hu W; Yang J; Qiu X; Ma G; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1196. PubMed ID: 36544650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volumetric parameters derived from FLT-PET performed at completion of treatment predict efficacy of Carbon-ion Radiotherapy in patients with locally recurrent Nasopharyngeal Carcinoma.
    Hu J; Yang Z; Gao J; Hu W; Yang J; Qiu X; Zhang Y; Ma G; Kong L; Lu JJ
    J Cancer; 2020; 11(23):7073-7080. PubMed ID: 33123296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
    Hu J; Huang Q; Hu W; Liang F; Gao J; Yang J; Qiu X; Zhang H; Zhang G; Lu JJ; Kong L
    Oral Oncol; 2024 Apr; 151():106683. PubMed ID: 38387259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients.
    Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F
    PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography/computed tomography for outcome of carbon ion radiotherapy in patients with head and neck mucosal malignant melanoma.
    Inubushi M; Saga T; Koizumi M; Takagi R; Hasegawa A; Koto M; Wakatuki M; Morikawa T; Yoshikawa K; Tanimoto K; Fukumura T; Yamada S; Kamada T
    Ann Nucl Med; 2013 Jan; 27(1):1-10. PubMed ID: 22914968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value comparison between (18)F-FLT PET/CT and (18)F-FDG PET/CT volume-based metabolic parameters in patients with head and neck cancer.
    Hoshikawa H; Mori T; Yamamoto Y; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
    Clin Nucl Med; 2015 Jun; 40(6):464-8. PubMed ID: 25546204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node standardized uptake values at pre-treatment
    Jeong Y; Baek S; Park JW; Joo JH; Kim JS; Lee SW
    Br J Radiol; 2017 Mar; 90(1071):20160239. PubMed ID: 28008776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic tumor volume and conformal radiotherapy based on prognostic PET/CT for treatment of nasopharyngeal carcinoma.
    Fei Z; Chen C; Huang Y; Qiu X; Li Y; Li L; Chen T
    Medicine (Baltimore); 2019 Jul; 98(28):e16327. PubMed ID: 31305420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
    Zhao F; Cui Y; Li M; Fu Z; Chen Z; Kong L; Yang G; Yu J
    Nucl Med Biol; 2014 Sep; 41(8):710-5. PubMed ID: 24929963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT with 3'-deoxy-3'-[18F]fluorothymidine for lung cancer patients receiving carbon-ion radiotherapy.
    Saga T; Koizumi M; Inubushi M; Yoshikawa K; Tanimoto K; Fukumura T; Miyamoto T; Nakajima M; Yamamoto N; Baba M
    Nucl Med Commun; 2011 May; 32(5):348-55. PubMed ID: 21326122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of SUV-based parameters derived from pre-treatment (18)F-FLT PET/CT for short-term outcome with head and neck cancers.
    Hoshikawa H; Yamamoto Y; Mori T; Kishino T; Fukumura T; Samukawa Y; Mori N; Nishiyama Y
    Ann Nucl Med; 2014 Dec; 28(10):1020-6. PubMed ID: 25179522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment
    Ma G; Gu B; Hu J; Kong L; Zhang J; Li Z; Xue Y; Lu J; Cao J; Cheng J; Zhang Y; Song S; Yang Z
    Ann Nucl Med; 2021 Jul; 35(7):834-842. PubMed ID: 33913102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy.
    Shrestha S; Higuchi T; Shirai K; Tokue A; Shrestha S; Saitoh JI; Hirasawa H; Ohno T; Nakano T; Tsushima Y
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1220-1227. PubMed ID: 31758225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of the Metabolic Parameters of
    Wang D; Liu X; Wang W; Huo L; Pan Q; Ren X; Zhang F; Hu K
    Front Oncol; 2021; 11():698744. PubMed ID: 34490094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of treatment response in patients with locally advanced cervical cancer using midtreatment PET/MRI during concurrent chemoradiotherapy.
    Vojtíšek R; Baxa J; Kovářová P; Almortaza A; Hošek P; Sukovská E; Tupý R; Ferda J; Fínek J
    Strahlenther Onkol; 2021 Jun; 197(6):494-504. PubMed ID: 33492444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of pretreatment 18F-FDG PET-CT for nasopharyngeal carcinoma patients.
    Huang Y; Feng M; He Q; Yin J; Xu P; Jiang Q; Lang J
    Medicine (Baltimore); 2017 Apr; 96(17):e6721. PubMed ID: 28445287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
    Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
    J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.